USNAHIGH SIGNALOPERATIONAL10-K

USNA underwent a major business transformation through acquisitions (Hiya and Rise), expanding from a direct-selling nutrition company to an omni-channel platform encompassing supplements, functional foods, and personal care across multiple distribution channels.

The dramatic revenue increase of 307% to $1.1B indicates successful execution of the company's diversification strategy beyond traditional direct selling. However, the 74% decline in net income despite revenue growth suggests significant integration costs, margin compression, or operational inefficiencies that investors should monitor closely as the company scales its expanded business model.

Comparing 2026-03-16 vs 2025-03-12View on EDGAR →
FINANCIAL ANALYSIS

USNA's financial profile reflects a company in major transition, with revenue surging 307% to $1.1B while profitability collapsed 74% to $10.8M net income, indicating successful top-line growth but significant margin pressure from expansion efforts. Operating cash flow declined 63% to $22.3M despite higher revenues, while the company increased share buybacks to $27.5M and built inventory by 47%, suggesting management confidence in long-term prospects despite near-term operational challenges. The combination of explosive revenue growth with deteriorating profitability and cash generation signals a business transformation that requires careful monitoring of execution risk.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+307.1%
$260.6M$1.1B

Strong top-line growth of 307.1% — accelerating demand or successful expansion into new markets.

Share Buybacks
Cash Flow
+191.3%
$9.4M$27.5M

Share repurchases increased 191.3% — management returning capital, signals confidence in intrinsic value.

Net Income
P&L
-74.4%
$42.0M$10.8M

Net income declined 74.4% — review whether driven by operations, interest costs, or non-recurring items.

Operating Cash Flow
Cash Flow
-63.4%
$61.0M$22.3M

Operating cash flow fell 63.4% — earnings quality concerns; investigate working capital changes and non-cash items.

Inventory
Balance Sheet
+47.1%
$69.7M$102.6M

Inventory surged 47.1% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Operating Income
P&L
-43.6%
$66.3M$37.4M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Capital Expenditure
Cash Flow
+37.2%
$10.1M$13.8M

Capital expenditure jumped 37.2% — major investment cycle underway; assess returns on deployment.

Interest Expense
P&L
+36.5%
$192K$262K

Interest expense surged 36.5% — significant debt increase or rising rates materially impacting earnings.

SG&A Expense
P&L
+28.1%
$263.3M$337.4M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Cash & Equivalents
Balance Sheet
-12.9%
$181.8M$158.4M

Cash decreased 12.9% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2026-03-16
PRIOR — 2025-03-12
ADDED
There were 18,456,935 shares of the registrant s common stock outstanding as of March 13, 2026.
develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold throughout the world.
In 2025, we generated $925 million in net sales and finished the year with approximately 387,000 active Customers in our core nutritional business.
Mainland China ( China ) is our largest market and single largest source of revenue, representing approximately 41.3% of net sales and approximately 49.9% of core nutritional active Customers.
In 2022, we acquired Rise and have expanded Rise's product offering, distribution channel, and customer base over the last three years.
+7 more — sign up free →
REMOVED
There were 18,904,526 shares of the registrant s common stock outstanding as of March 7, 2025.
is a global direct selling and direct-to-consumer nutrition, personal health and wellness company.
In 2024, we generated $855 million in net sales and finished the year with approximately 454,000 direct selling active Customers.
Consequently, we now operate and sell products through both direct selling and direct-to-consumer channels.
Mainland China ( China ) is our largest direct selling market and single largest source of revenue, representing approximately 48.4% of net sales and approximately 50.2% of direct selling active Customers.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →